Refractec Focuses On CK Astigmatism, Post-LASIK Treatment Indications
This article was originally published in The Gray Sheet
Executive Summary
Refractec expects approval of a presbyopia indication for its CK Blended Vision radio wave procedure in early 2004, the company announced Sept. 30
You may also be interested in...
LASIK Manufacturers Rally For Eye Institute; Youthful Market In View For Visx
The National Alliance for Eye & Vision Research is proposing that the budget for the National Eye Institute increase roughly 12.3% to $711 mil. in fiscal 2004
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.